Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

4.90
+0.08001.66%
Post-market: 4.900.00000.00%18:03 EDT
Volume:915.56K
Turnover:4.46M
Market Cap:220.49M
PE:-2.26
High:4.97
Open:4.78
Low:4.65
Close:4.82
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:0.84
T/O Rate:5.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:0.83
PE(LYR):-2.60

Loading ...

Sionna Therapeutics Cut to Neutral from Buy by BTIG

Dow Jones
·
Aug 11

Sionna Therapeutics, Inc. : Btig Cuts to Neutral from Buy

THOMSON REUTERS
·
Aug 11

Sionna Therapeutics, Inc. : Jonestrading Cuts to Hold Rating

THOMSON REUTERS
·
Aug 11

Small U.S. Stocks Decrease; Sionna Therapeutics Posts Biggest Loss

Dow Jones
·
Aug 11

Sionna Therapeutics downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
Aug 11

Sionna Therapeutics: Hold Rating Maintained as Disappointing CF Data Drive Price Target Cut from $60 to $6

TIPRANKS
·
Aug 11

Sionna Therapeutics downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Aug 11

Top Midday Decliners

MT Newswires Live
·
Aug 11

Sionna Therapeutics downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Aug 11

Citizens downgrades Sionna Therapeutics as SION-719 miss questions NBD1 thesis

TIPRANKS
·
Aug 11

U.S. Stocks on the MOVE-Microsoft, Coastal Financial

Reuters
·
Aug 11

Sionna Therapeutics falls -92.0%

TIPRANKS
·
Aug 11

Why Sionna Therapeutics Stock is Crashing 92% to a Record Low

Dow Jones
·
Aug 11

Sionna Therapeutics downgraded to Market Perform from Outperform at Citizens

TIPRANKS
·
Aug 10

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Top Midday Stories: Intel Offers $15 Billion of Common Stock; Microsoft to Ramp Up Production of Homegrown AI Chip

MT Newswires Live
·
Aug 10

Sionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond James

TIPRANKS
·
Aug 10

Sionna Therapeutics upgraded to Sector Perform from Underperform at RBC Capital

TIPRANKS
·
Aug 10

Sionna Therapeutics, Inc. : RBC Raises to Sector Perform from Underperform; Cuts Target Price to $5 from $23

THOMSON REUTERS
·
Aug 10

Tenax, Sionna Shares Sink After Trial Failures

Dow Jones
·
Aug 10